Vision Correction Clinical Trial
Official title:
Acceptance & Tolerance Study of Multifocal Contact Lenses by Functional Emmetropes
| Verified date | April 2017 |
| Source | Johnson & Johnson Vision Care, Inc. |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The primary objective of this study is to determine the retention rate over a two month period of vision correction in emmetropic, presbyopes fitted with multifocal contact lenses.
| Status | Completed |
| Enrollment | 113 |
| Est. completion date | September 1, 2015 |
| Est. primary completion date | September 1, 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 40 Years to 70 Years |
| Eligibility |
Inclusion Criteria: 1. The subject must read, understand and sign the Statement of Informed Consent and receive a fully executed copy of the form. 2. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol. 3. The subject must be between 40 and 70 years of age. 4. The subject's vertex corrected spherical equivalent distance refraction must be in the range of -1.00 to +2.00 in each eye. 5. The subject's refractive cylinder must be less than or equal to -0.75 D in each eye. 6. The subject's ADD power must be in the range of +0.75 D to +2.50. 7. The subject must have best corrected visual acuity of 20/25 or better in each eye. Exclusion Criteria: 1. Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued). 2. Any ocular or systemic allergies that contraindicate contact lens wear. 3. Any ocular or systemic disease, autoimmune disease, or use of medication, that contraindicates contact lens wear. 4. Any ocular abnormality that may interfere with contact lens wear. 5. Use of any ocular medication, with the exception of rewetting drops. 6. Any previous intraocular surgery (e.g. radial keratotomy, PRK, LASIK, etc.). 7. Any grade 3 or greater slit lamp findings (e.g. edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) which may contraindicate contact lens wear. 8. History of herpetic keratitis. 9. Any ocular infection or inflammation. 10. Any corneal distortion or irregular cornea. 11. History of binocular vision abnormality or strabismus. 12. Any infectious disease (e.g. hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g. HIV). 13. History of diabetes. 14. Current or previous history of being prescribed a correction for distance vision. 15. Current or previous history of contact lens wear. 16. Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment. |
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Ocular Technology Group-International | London | |
| United States | Tallahassee Eye Center | Pensacola | Florida |
| Lead Sponsor | Collaborator |
|---|---|
| Johnson & Johnson Vision Care, Inc. |
United States, United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Proportion of Successful Contact Lens Wearers | Proportion of Successful contact lens wearers is based on a subject's responses to two questionnaire items, "Overall Quality of Vision" and "Overall Comfort". Each item uses a 6 response like-rt scale (0= Not Applicable, 1=Excellent, 2=Very Good, 3=Good, 4=Fair and 5=Poor). The data from each item was dichotomized into two groups. If a subject responded "Excellent", "Very Good" or "Good" then the response=1, otherwise the response=0. The proportion of subjects with response=1 was reported as the proportion of successful contact lens wearers. | 2 months post wear |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02036320 -
A Non-dispensing Fit Evaluation of Investigational Limbal Ring Soft Contact Lenses With Polyvinylpyrrolidone (PVP) in Asian Eyes
|
N/A | |
| Completed |
NCT00630305 -
Endothelial Bleb Response With Toric Lenses
|
N/A | |
| Completed |
NCT00638846 -
Performance of Two Silicone Hydrogel Toric Contact Lenses
|
N/A | |
| Completed |
NCT01061294 -
Evaluation of Outcomes Using the AMO Advanced Customvueâ„¢ iLasik Procedure
|
Phase 4 | |
| Completed |
NCT01197859 -
Three Month Clinical Evaluation of the Contamac 74% Silicone Hydrogel Contact Lens
|
N/A |